Skip to main content
Clinical Trials/NCT03900455
NCT03900455CompletedNot Applicable

Effectiveness of the Use of a Polyurethane Foam Multilayer Dressing in the Sacral Area, in Addition to Standard Healthcare, to Prevent the Onset of Pressure Ulcer in Patients at Risk. Multicentric Randomized Controlled Trial

Istituto Ortopedico Rizzoli18 sites in 1 country711 target enrollmentStarted: October 21, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
711
Locations
18
Primary Endpoint
Rate of any type of pressure ulcer in the sacral area.

Study Overview

Brief Summary

The aim of the present study was to assess whether the application of a multilayered dressing made of hydrocellular polyurethane foam conformed to the sacral area (MSP) in addition to standard preventive care reduces the rate of pressure ulcer (PU) and their severity in population at risk admitted in acute care Hospital.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients at risk to develop Pressure Ulcer (Braden scale <17)
  • without sacrum Pressure Ulcer
  • Patients or legal guardians who give their consent to take part in the study

Exclusion Criteria

  • Patients with known allergy to the product being tested or dermatological diseases that prevent the use of topical products

Outcomes

Primary Outcomes

Rate of any type of pressure ulcer in the sacral area.

Time Frame: On the seventh day of hospitalization or upon discharge from hospital, if that occurs before the seventh day

The ulcer will be classified according to the National Pressure Ulcers Advisory Panel Classification. Pressure ulcer are classified and described through the use of staging systems. Staging systems describe the extent of tissue loss and the physical appearance of the injury caused by pressure and/or shear. From stage 1 (intact skin) to Stage 4 (Full-thickness skin and tissue loss).

Secondary Outcomes

  • Skin irritation/damage due to the adhesive dressing(On the seventh day of hospitalization or upon discharge from hospital, if that occurs before the seventh day)
  • Pressure Ulcer Rate in the Sacral Area of Category≥ II(On the seventh day of hospitalization or upon discharge from hospital, if that occurs before the seventh day)
  • Number of dressing used per patient.(On the seventh day of hospitalization or upon discharge from hospital, if that occurs before the seventh day)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (18)

Loading locations...

Similar Trials